EN
抗体药类似物
Research Grade Infliximab
All
TD-HF879036_1.jpg
TD-HF879036_2.jpg
TD-HF879036_3.jpg
  • CatalogTD-HF879036
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsTA-650,cA2,CAS:170277-31-3
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Infliximab


Catalog No. TD-HF879036
Species reactivity Human
Applications Research Grade Biosimilar
Host species Chimeric
Isotype IgG1, kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a, TNF-alpha, Tumor necrosis factor, TNFSF2, TNFA, Cachectin, ICD1
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P01375
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names TA-650,cA2,CAS:170277-31-3
Background Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α. Infliximab prevents the interaction of TNF-α with TNF-α receptor (TNFR1 and TNFR2). Infliximab has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy research.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HF879036_1.jpg
SEC-HPLC
 

 

SEC-HPLC detection for Research Grade Infliximab.

TD-HF879036_2.jpg
Bioactivity
 

 

Detects Human TNFa/TNF-alpha in indirect ELISAs.

TD-HF879036_3.jpg
SDS-PAGE
 

 

SDS-PAGE for Research Grade Infliximab.